Licensing agreements with all patent holders have been completed Enables Horizon to use gene editing directly as a therapeutic New technology has immediate applications in biomanufacturing, diagnostics, cell and gene therapy Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), the world leader in the application of gene editing technologies, today announces […]
Company’s New 96 Well Plate Reader Offers Rapid Testing for Phytophthora, CLas, and Ralstonia Plant Pathogens with High Sensitivity, Ease of Use and Affordability Baltimore, Maryland Baltimore biotech firm, PathSensors, Inc., announced today it will be launching its Navigator instrument platform, which allows for high-throughput testing for plant pathogens such as Phytophthora, Candidatus Liberibacter asiaticus […]
Developed to support assay development and validation for detection of anti-drug antibodies Uppsala, Sweden: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has launched a new version of its anti-drug antibody (ADA) solution for the immunogenicity market. Immunogenicity testing is […]
Chromatrap® announces that BioLegend, a major US-based manufacturer and supplier of reagents and kits for biomedical research, has chosen their novel solid-state ChIP technology to power a new range of faster and more efficient chromatin immunoprecipitation kits. These new kits will combine BioLegend’s expertise in developing the Go-ChIP-Grade™ antibodies that are validated for ChIP assays with the patented […]
Location: Cambridge Abcam extends a pre-existing license and supply agreement with Horizon by exercising an exclusivity provision for the period from July 2017 through June 2018 Horizon’s knockout cell models have enabled Abcam to validate its antibody catalogue at an unprecedented scale Reagent validation is an important component of efforts to improve reproducibility in medical […]
Extended RAS Panel helps identify colorectal cancer patients eligible for Amgen’s Vectibix SAN DIEGO—Illumina, Inc. (NASDAQ:ILMN) today announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit that meets the newly published guidelines for evaluation of colorectal cancer from the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), the Association for Molecular Pathology(AMP), and the American Society of Clinical Oncology (ASCO)1. […]
PLEASANTON, Calif. — Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, acquired Trinean today. Trinean’s DropSense systems measure protein, DNA and RNA concentration in biologics and genomics samples. This is Unchained Labs’ 5th acquisition in just over 2 years. DropSense96 is the only system out there that […]
Company completes Series D funding and adds two new directors to board (ANN ARBOR, Mich.) Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the completion of a Series D funding raise of $12.2 million. The company also announced the addition of two new directors to its board, positioning the […]
Life sciences executive brings proven ability to develop and drive adoption of transformational technologies SOUTH SAN FRANCISCO, Calif. – June 29, 2017 – Biodesy, Inc., the next-generation protein analysis company, today announced that Dominique Bridon, PhD, has been appointed Chief Executive Officer and a member of the board of directors, effective immediately. Dr. Bridon brings […]
Nikon Corporation (Kazuo Ushida, President, Tokyo) announced a revision of its business segments as part of organizational reform as of today. These business segment changes will be reflected in the company’s consolidated financial results for the second quarter of the fiscal year ending March 31, 2018. Old Segments Segment Business Unit Precision Equipment Business Semiconductor […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

